Business
ResMed (ASX:RMD) share price returned 20% in 1 year. Where to in 2021?
Medical devices company ResMed Inc (ASX: RMD) had a successful year in 2020, with operating profit growing by more than 24%. As a result, the Resmed share price returned more than 20% for the investor. This, in a year dominated by the coronavirus pandemic.
Can the company improve on this share price performance in 2021? Let’s take a look at the opportunities and challenges ahead for ResMed this year.
First, the numbers…
For the full year of FY20, the company’s operating profit grew 24% to US$890.9 million.
ResMed then followed this up with a strong first-quarter FY21, with first-quarter revenues increasing by 10% against the prior comparative period to US$751.9 million, while net operating profit surged 27%.
A key driver of…
-
Noosa News19 hours agoSydney Film Festival 2025 Is Opening with Alison Brie- and Dave Franco-Starring Australian Film ‘Together’
-
Noosa News10 hours agoBunnings strikes agreement to address concerns of ‘terrified’ plant growers
-
Noosa News19 hours agoWhether You’re Keen on a Whitsundays or Bali Getaway, Jetstar Has Just Dropped 40,000-Plus Sale Fares
-
Noosa News10 hours agoLDV Automotive Australia accused of misrepresenting durability of T60 and G10 models following rust concerns